GSK
  • About
  • Press Releases
    Latest
    English 259
  • Assets
    Images
    Files
    Other
  • Resources
    Website
    facebook twitter youtube linkedin instagram
GSK
2 years ago ⋅ English ⋅ 4 min read
Newsroom

Medicines and Healthcare products Regulatory Agency authorises GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults

For media and investors only- Authorisation will help protect adults 60 years of age and older in the UK from RSV disease for the first time- In the UK, RSV leads to an estimated 14,000... Read More

GSK
2 years ago ⋅ English ⋅ 3 min read
Newsroom

GSK completes acquisition of BELLUS Health

For media and investors onlyGSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a biopharmaceutical company wor... Read More

GSK
2 years ago ⋅ English ⋅ 3 min read
Newsroom

GSK receives US FDA Fast Track designation for investigational vaccine against gonorrhoea

For media and investors only- Fast Track designation accelerates the vaccine candidate’s path to US FDA submission for the prevention of Neisseria gonorrhoeae infection- Gonorrhoe... Read More

GSK
2 years ago ⋅ English ⋅ 4 min read
Newsroom

Japan’s Ministry of Health, Labour and Welfare approves Shingrix for the prevention of shingles in at-risk adults aged 18 and over

For media and investors only- Approval expands the number of people who can be protected against shingles, now including all adults considered at increased risk by their healthcare prov... Read More

GSK
2 years ago ⋅ English ⋅ 4 min read
Newsroom

GSK receives positive CHMP opinion recommending authorisation of daprodustat for symptomatic anaemia associated with chronic kidney disease in adults on chronic maintenance dialysis

For media and investors onlyGSK plc (LSE/NYSE: GSK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive... Read More

GSK
2 years ago ⋅ English ⋅ 1 min read
Newsroom

Statement - Zantac (ranitidine) litigation

For media and investors onlyGSK plc (LSE/NYSE: GSK) today confirmed it has reached a confidential settlement with James Goetz, and the case he filed in California state court, set to be... Read More

  • ‹
  • 1
  • 2
  • ...
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ...
  • 43
  • 44
  • ›

Wire Association

© Copyright 2025
Wire Association. All rights reserved.
Helpful Links
  • Login
  • Home
  • About
  • Contact
Press Releases
  • Pricing
  • News Center
  • Editorial Guidelines
  • Editorial Team
Other
  • Terms & Conditions
  • Privacy Policy
  • Sitemap